Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VENT homeobox pseudogene 5 (VENTXP5) is a retrotransposed pseudogene, derived from the VENTX homeobox gene family. Like other homeobox pseudogenes, VENTXP5 contains sequence similarity to functional homeobox genes (which encode DNA-binding transcription factors involved in development and differentiation), but VENTXP5 itself does not produce a functional protein product due to disabling mutations and the absence of necessary regulatory elements. It is not expressed as a functional molecule and has no known biological role, disease association, or therapeutic relevance. The pseudogene classification is supported by comparative genomics and the lack of protein-coding potential. There is no evidence that VENTXP5 is a functional therapeutic target, nor any indication it affects drug action or patient selection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VENT homeobox pseudogene 5 (VENTXP5).